By Nikita Maria Jino, Kumar Tanishk and Jonathan Stempel June 11 (Reuters) - A Chinese biotechnology company sued the U.S.
Shares of Chinese biopharmaceutical company WuXi AppTec surged Wednesday as investors turned to healthcare stocks amid a global tech selloff and were encouraged by fresh policy support from Beijing.
June 11 (Reuters) - WuXi AppTec said on Thursday it has filed a complaint at a U.S. district court against the Department of Defense for including the company in a list linked to the Chinese military.
Shares of Chinese pharmaceutical major WuXi AppTec tumbled after the U.S. Defense Department included the company in its list of entities deemed to have ties with Beijing's military. WuXi AppTec's ...
(Reuters) -U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi AppTec had transferred U.S. intellectual property to ...
A calligraphy exhibition is held in Beijing to celebrate the 40th anniversary of the establishment of the Wuxi Calligraphy Association from August 29 to September 2, 2022. The photo presents the work ...
Big Pharma CEOs' visits to Beijing, AstraZeneca's manufacturing Chinese wall and an allegation against WuXi AppTec made our news this week. (JavierHuras/iStock/Getty ...
BEIJING - Wuxi, a Chinese manufacturing hub, tightened its Covid-19 control measures on Sunday (July 3) after reporting 31 new coronavirus cases, as the country continues battling clusters of the ...
The company says it suffered substantial reputational and operational harm after being placed on a Pentagon blacklist.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results